| Apr 30 2020 |
OSHA Issues Enforcement Guidance on Decontamination of N95 Respirators in Healthcare |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 30 2020 |
Governor Whitmer Extends Restriction Suspensions for Health Care Providers |
Varnum LLP |
| Apr 30 2020 |
Medicare Part B Suppliers No Longer Able to Receive Advance Payment Funds |
Polsinelli PC |
| Apr 30 2020 |
New York’s Governor Outlines Plan to Re-Open Businesses |
Proskauer Rose LLP |
| Apr 30 2020 |
Patent’s Explicit Description of Claimed Advantages Defeats § 101 Challenge |
McDermott Will & Schulte LLP |
| Apr 30 2020 |
Using Health Data in Europe During COVID-19 |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 30 2020 |
CMS Proceeds With Controversial 340B Acquisition Cost Survey During COVID-19 Pandemic – Due May 15, 2020 |
Polsinelli PC |
| Apr 30 2020 |
Problematic Developments in Nursing Homes During the COVID-19 Pandemic |
Stark & Stark |
| Apr 30 2020 |
The California Department of Managed Health Care Extends the Phase-In Period for the General Licensure Regulation |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 29 2020 |
U.S. Supreme Court Holds Federal Government Accountable for ACA Promises |
Barnes & Thornburg LLP |
| Apr 29 2020 |
Episode 9: Clinical Trials in the Time of COVID-19 |
Foley & Lardner LLP |
| Apr 29 2020 |
Bill Extends Medicare Telehealth Coverage for Therapy Providers |
McDermott Will & Schulte LLP |
| Apr 29 2020 |
Healthcare Rehabilitation Provider Pays $4 Million to Settle False Claims Act Allegations |
Tycko & Zavareei LLP |
| Apr 29 2020 |
COVID-19: Massachusetts Governor Extends Non-Essential Business Closures to May 18, 2020 |
Pierce Atwood LLP |
| Apr 29 2020 |
Pharmacy Groups Request COVID-19 Testing Authority for California Pharmacists |
Much Shelist, P.C. |
| Apr 29 2020 |
COVID-19: Testing and Treatment to Uninsured Patients: Reimbursement Available Under New HHS Payment Program |
K&L Gates LLP |
| Apr 29 2020 |
COVID-19: CMS Issues Telehealth Guidance for State Medicaid and CHIP Programs |
Foley & Lardner LLP |
| Apr 29 2020 |
HRSA COVID-19 Uninsured Program Portal Is Now Open |
Squire Patton Boggs (US) LLP |
| Apr 29 2020 |
Connecticut Governor Expands Health Care Workforce, Access to Telehealth Services and Issues Other Important Health Care Updates in New Executive Orders |
Robinson & Cole LLP |
| Apr 29 2020 |
CMS Continues to Refine Survey and Infection Control Guidance for Long Term Care Facilities During the COVID-19 Pandemic |
McDermott Will & Schulte LLP |
| Apr 29 2020 |
COVID-19 and Lab Testing: What’s the Story Behind the Story? |
Mintz |
| Apr 28 2020 |
Child Support and Payment of Children's Other Expenses |
Varnum LLP |
| Apr 28 2020 |
New York Employers: Engage In The Interactive Dialogue With Medical Marijuana Users |
Jackson Lewis P.C. |
| Apr 28 2020 |
COVID-19: CMS Publishes Explanatory Guidance on Stark Blanket Waivers |
Foley & Lardner LLP |
| Apr 28 2020 |
Managing And Mitigating The Risk Of Qui Tam Actions In The Wake Of COVID-19 |
Godfrey & Kahn S.C. |
| Apr 28 2020 |
Face or Fingerprint? The DEA Revisits Biometric Identifiers for e-Prescribing Controlled Substances |
Epstein Becker & Green, P.C. |
| Apr 28 2020 |
Adjusting to Alice: USPTO’s View of Its Examination Guidelines |
Foley & Lardner LLP |
| Apr 28 2020 |
OIG Penalties Expand to Grant and Contract Fraud |
McDermott Will & Schulte LLP |
| Apr 28 2020 |
New Jersey’s Post-COVID-19 ‘Road Back’ Plan Full of Red Lights |
Jackson Lewis P.C. |
| Apr 28 2020 |
COVID-19 Likely Responsible for Hike in OSHA “Fatality/Catastrophe” Investigations at Healthcare Facilities |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 28 2020 |
FDA Issues Warning Letters to Companies Marketing CBD Products for Treatment of Disease and Addiction |
Keller and Heckman LLP |
| Apr 28 2020 |
The Return of Balance and Proportionality |
Womble Bond Dickinson (US) LLP |
| Apr 27 2020 |
Guidance Released on Seeking Reimbursement for COVID-19 Testing and Treatment to Uninsured Individuals |
Jackson Lewis P.C. |
| Apr 27 2020 |
Supreme Court Rules in Favor of Health Insurers Under Affordable Care Act’s Risk Corridor Program |
Squire Patton Boggs (US) LLP |
| Apr 27 2020 |
COVID-19: Understanding HHS’s Plans To Disperse Provider Relief Funds Authorized By The CARES Act |
Foley & Lardner LLP |
